LRP5 and osteosarcoma: Based on the discovery of Wnt ligands, LRP5/6 co-receptors, or cytoplasmic β-catenin staining, some investigators claimed that osteosarcoma samples had aberrant Wnt/β-catenin activation mediated by an autocrine mechanism.